Hepatic insulin resistance decreases liver response to insulin signaling by interrupting the insulin-induced inhibition of hepatic glucose production, which leads to hyperlipidemia, hyperglycemia, liver disease, and type 2 diabetes [26,27]. This evidence concerns the gene INS and hyperlipidemia.